HHS Hopes To Hike Use Of Experimental Monkeypox Drug As FDA Collects Data

By Jessica Karins / August 4, 2022 at 5:42 PM
HHS will seek to make the smallpox drug tecovirimat, or TPOXX, more widely available for the treatment of monkeypox with the department’s expanded powers under a new public health emergency declaration for monkeypox, officials confirmed Thursday (Aug. 4), but they were vague on how they would do so. In announcing that he would declare a monkeypox PHE, HHS Secretary Xavier Becerra stopped short of issuing a declaration under Section 564 of the Federal Food, Drug and Cosmetics Act that would...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.